The VACC-6 is a delayed-action area weapon that operates through catalytic aerosol chemistry rather than conventional explosive mechanics. The device releases a proprietary suspended catalyst compound — developed under LAZARUS PHARMACEUTICALS' advanced biochemical division — that remains inert in open air but undergoes rapid exothermic oxidation when it contacts the compressed, humidified air of sealed respiratory systems: lungs, rebreathers, HVAC circulation loops, and sealed habitat environments. The resulting reaction is not a traditional explosion but a localized chemical combustion event occurring at the point of inhalation or intake, typically producing severe internal thermal trauma and toxic oxidation byproducts simultaneously.

The tactical novelty of the VACC-6 is its discrimination logic: the catalytic compound is essentially harmless in ambient atmospheric conditions but becomes a precision incendiary the moment it enters a system designed to concentrate and circulate air. This makes it extraordinarily effective in environments where conventional explosives cannot be used — pressurized habitats, clean-room facilities, medical bays, and sealed transport vehicles. Targets wearing open-face armor survive unharmed while those in sealed suit systems suffer catastrophic respiratory failure. The compound disperses to safe concentrations within 90 minutes in open environments.

LAZARUS PHARMACEUTICALS has consistently denied that the VACC-6 was developed as a weapons system, characterizing the catalytic compound as a derivative of their atmospheric remediation research. Internal documents recovered by investigative journalists suggest otherwise. The weapon is called 'Breathseed' by operators because of the delay between dispersal and effect — you plant it in the air, and it grows when someone breathes.